Home » Newsletters » BioWorld Science

BioWorld Science

April 29, 2002

View Archived Issues

Potent and selective CDK2 inhibitors with antitumor activity reported at ACS meeting

Major European launch for Viread

Lumigan approved by European Commission, introduced in three countries

Egis and Servier select new anxiolytic development candidate

Broad-spectrum beta-lactamase inhibitor useful in combination with penicillins and cephalosporins

New oxazolidinone AZD-2563 further characterized preclinically at ECCMID

Myfortic affords therapeutic exposure to active moiety in pediatric renal transplant patients

Caspase inhibitor protects against hepatic I/R injury in rat model

GSK's naratriptan will be developed and marketed by Sumitomo in Japan

Vascular remodeling following organ transplant effectively inhibited by new somatostatin analogue

Anti-TIRC7 MAb prevents acute cardiac allograft rejection

Vertex publishes first-quarter 2002 results

Lorus presents data on Virulizin at AACR

EMEA accepts Thalomid MAA for review

Companies collaborate to develop drugs targeting ABC transporters

Mylovenge designated orphan drug for treatment of multiple myeloma

Faslodex approved in U.S. for tamoxifen-resistant breast cancer

Trial initiated for NMP48 blood test for prostate cancer

Orphan Medical licenses rights to butamben

GenPhar develops vaccines for HIV, hepatitis B, hepatitis C and Marburg virus

Motilin antagonists useful for treatment of GI hypermotility

Pharmacyclics claims metallotexaphyrins and use in diagnosis and therapy

New Ilex compounds lower apolipoprotein and cholesterol levels

Cannabinoid receptor agonists reportedly useful for pain and Parkinson's disease

Agents for H. pylori infections designed at Yamanouchi

Inhibitors of JNKs useful for a wide range of conditions according to ARS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...